Abstract
The CRAFITY score: A promising prognostic predictor for patients with hepatocellular carcinoma treated with tyrosine kinase inhibitor and immunotherapy combinations
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have